{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T07:49:39Z","timestamp":1792136979323,"version":"4.4.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T00:00:00Z","timestamp":1784678400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T00:00:00Z","timestamp":1792108800000},"content-version":"vor","delay-in-days":86,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["1U01HL105268-01"],"award-info":[{"award-number":["1U01HL105268-01"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["K23HL161432"],"award-info":[{"award-number":["K23HL161432"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Lipids Health Dis"],"DOI":"10.1186\/s12944-026-03017-x","type":"journal-article","created":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T23:13:07Z","timestamp":1784675587000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Mental health-related quality of life is associated with sustained lipid-lowering therapy adherence after acute coronary syndrome"],"prefix":"10.1186","volume":"25","author":[{"given":"Asem H","family":"Ali","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine A.","family":"Tak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa M.","family":"Taylor-Yeremeeva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cassie R.","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carrie R.","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nico","family":"Fandino-Rubio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maritza","family":"Jerome","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darleen","family":"Lessard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catarina I.","family":"Kiefe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David D.","family":"McManus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khanh-Van","family":"Tran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,22]]},"reference":[{"issue":"7","key":"3017_CR1","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1001\/jama.2022.0358","volume":"327","author":"DL Bhatt","year":"2022","unstructured":"Bhatt DL, Lopes RD, Harrington RA. Diagnosis and treatment of acute coronary syndromes: a review. JAMA. 2022;327(7):662.","journal-title":"JAMA"},{"issue":"38","key":"3017_CR2","doi-asserted-by":"publisher","first-page":"e44237","DOI":"10.1097\/MD.0000000000044237","volume":"104","author":"MK Khan","year":"2025","unstructured":"Khan MK, Khan IA, Javed AM, Wazir A, Saleem H, Zohaib M, et al. Trends and disparities in acute coronary syndrome-related mortality in the United States: Implications for healthcare. Med (Baltim). 2025;104(38):e44237.","journal-title":"Med (Baltim)"},{"issue":"8","key":"3017_CR3","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1161\/ATVBAHA.123.319370","volume":"43","author":"H Khraishah","year":"2023","unstructured":"Khraishah H, Daher R, Garelnabi M, Karere G, Welty FK. Sex, racial, and ethnic disparities in acute coronary syndrome: novel risk factors and recommendations for earlier diagnosis to improve outcomes. ATVB. 2023;43(8):1369\u201383.","journal-title":"ATVB"},{"issue":"12","key":"3017_CR4","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1097\/MLR.0000000000000819","volume":"55","author":"L Nobel","year":"2017","unstructured":"Nobel L, Jesdale WM, Tjia J, Waring ME, Parish DC, Ash AS, From TRACE-CORE, Transitions, et al. Risks, and Actions in Coronary Events\u2014Center for Outcomes Research and Education). Med Care. 2017;55(12):1008\u201316.","journal-title":"Med Care"},{"issue":"9753","key":"3017_CR5","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1016\/S0140-6736(10)61350-5","volume":"376","author":"C Cholesterol Treatment Trialists","year":"2010","unstructured":"Cholesterol Treatment Trialists C. Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials. Lancet. 2010;376(9753):1670\u201381.","journal-title":"Lancet"},{"issue":"15","key":"3017_CR6","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1056\/NEJMoa040583","volume":"350","author":"CP Cannon","year":"2004","unstructured":"Cannon CP, Braunwald E, McCabe CH, Rader DJ, Rouleau JL, Belder R, et al. Intensive versus Moderate Lipid Lowering with Statins after Acute Coronary Syndromes. N Engl J Med. 2004;350(15):1495\u2013504.","journal-title":"N Engl J Med"},{"key":"3017_CR7","doi-asserted-by":"crossref","unstructured":"Rao SV, O\u2019Donoghue ML, Ruel M, Rab T, Tamis-Holland JE, Alexander JH et al. 2025 ACC\/AHA\/ACEP\/NAEMSP\/SCAI guideline for the management of patients with acute coronary syndromes: a report of the American college of cardiology\/American heart association joint committee on clinical practice guidelines. Circulation. 2025;151(13).","DOI":"10.1161\/CIR.0000000000001328"},{"key":"3017_CR8","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.ahj.2019.05.009","volume":"214","author":"MG Nanna","year":"2019","unstructured":"Nanna MG, Navar AM, Wang TY, Li S, Virani SS, Li Z, et al. Practice-level variation in statin use and low-density lipoprotein cholesterol control in the United States: Results from the Patient and Provider Assessment of Lipid Management (PALM) registry. Am Heart J. 2019;214:113\u201324.","journal-title":"Am Heart J"},{"issue":"9","key":"3017_CR9","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1001\/jamacardio.2021.1810","volume":"6","author":"CP Cannon","year":"2021","unstructured":"Cannon CP, De Lemos JA, Rosenson RS, Ballantyne CM, Liu Y, Gao Q, et al. Use of Lipid-Lowering Therapies Over 2 Years in GOULD, a Registry of Patients With Atherosclerotic Cardiovascular Disease in the US. JAMA Cardiol. 2021;6(9):1060.","journal-title":"JAMA Cardiol"},{"issue":"11","key":"3017_CR10","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1016\/j.clinthera.2023.08.011","volume":"45","author":"MC Bahit","year":"2023","unstructured":"Bahit MC, Korjian S, Daaboul Y, Baron S, Bhatt DL, Kalayci A, et al. Patient adherence to secondary prevention therapies after an acute coronary syndrome: a scoping review. Clin Ther. 2023;45(11):1119\u201326.","journal-title":"Clin Ther"},{"issue":"7","key":"3017_CR11","doi-asserted-by":"publisher","first-page":"e011765","DOI":"10.1161\/JAHA.118.011765","volume":"8","author":"CK Bradley","year":"2019","unstructured":"Bradley CK, Wang TY, Li S, Robinson JG, Roger VL, Goldberg AC, et al. Patient-reported reasons for declining or discontinuing statin therapy: insights from the PALM Registry. JAHA. 2019;8(7):e011765.","journal-title":"JAHA"},{"issue":"1","key":"3017_CR12","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1002\/clc.23935","volume":"46","author":"NR Desai","year":"2023","unstructured":"Desai NR, Farbaniec M, Karalis DG. Nonadherence to lipid-lowering therapy and strategies to improve adherence in patients with atherosclerotic cardiovascular disease. Clin Cardiol. 2023;46(1):13\u201321.","journal-title":"Clin Cardiol"},{"issue":"1","key":"3017_CR13","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1186\/s12944-024-02363-y","volume":"23","author":"J Cao","year":"2024","unstructured":"Cao J, Guan W, Nomura SO, Bhatia HS, Garg PK, Tsai MY. Factors associated with lipid lowering therapy in the multi-ethnic study of atherosclerosis. Lipids Health Dis. 2024;23(1):375.","journal-title":"Lipids Health Dis"},{"issue":"4","key":"3017_CR14","first-page":"347","volume":"8","author":"R Mathews","year":"2015","unstructured":"Mathews R, Peterson ED, Honeycutt E, Chin CT, Effron MB, Zettler M, et al. Early Medication Nonadherence After Acute Myocardial Infarction. Circ: Cardiovasc Qual Outcomes. 2015;8(4):347\u201356.","journal-title":"Circ: Cardiovasc Qual Outcomes"},{"key":"3017_CR15","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.jpsychores.2016.09.003","volume":"90","author":"J Crawshaw","year":"2016","unstructured":"Crawshaw J, Auyeung V, Norton S, Weinman J. Identifying psychosocial predictors of medication non-adherence following acute coronary syndrome: A systematic review and meta-analysis. J Psychosom Res. 2016;90:10\u201332.","journal-title":"J Psychosom Res"},{"issue":"8","key":"3017_CR16","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1007\/s11136-010-9671-z","volume":"19","author":"R Tavella","year":"2010","unstructured":"Tavella R, Air T, Tucker G, Adams R, Beltrame JF, Schrader G. Using the Short Form-36 mental summary score as an indicator of depressive symptoms in patients with coronary heart disease. Qual Life Res. 2010;19(8):1105\u201313.","journal-title":"Qual Life Res"},{"issue":"2","key":"3017_CR17","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1007\/s12160-013-9544-0","volume":"47","author":"IM Kronish","year":"2014","unstructured":"Kronish IM, Rieckmann N, Burg MM, Alc\u00e1ntara C, Davidson KW. The Psychosocial Context Impacts Medication Adherence After Acute Coronary Syndrome. ann behav med. 2014;47(2):158\u201364.","journal-title":"ann behav med"},{"issue":"12","key":"3017_CR18","doi-asserted-by":"publisher","first-page":"e2246317","DOI":"10.1001\/jamanetworkopen.2022.46317","volume":"5","author":"ME Lapa","year":"2022","unstructured":"Lapa ME, Swabe GM, Rollman BL, Muldoon MF, Thurston RC, Magnani JW. Assessment of Depression and Adherence to Guideline-Directed Medical Therapies Following Percutaneous Coronary Intervention. JAMA Netw Open. 2022;5(12):e2246317.","journal-title":"JAMA Netw Open"},{"issue":"6","key":"3017_CR19","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/j.jpsychores.2008.06.004","volume":"65","author":"BD Thombs","year":"2008","unstructured":"Thombs BD, Ziegelstein RC, Stewart DE, Abbey SE, Parakh K, Grace SL. Physical health status assessed during hospitalization for acute coronary syndrome predicts mortality 12 months later. J Psychosom Res. 2008;65(6):587\u201393.","journal-title":"J Psychosom Res"},{"issue":"1","key":"3017_CR20","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1186\/s12955-021-01761-5","volume":"19","author":"M Suhail","year":"2021","unstructured":"Suhail M, Saeed H, Saleem Z, Younas S, Hashmi FK, Rasool F, et al. Association of health literacy and medication adherence with health-related quality of life (HRQoL) in patients with ischemic heart disease. Health Qual Life Outcomes. 2021;19(1):118.","journal-title":"Health Qual Life Outcomes"},{"key":"3017_CR21","doi-asserted-by":"crossref","unstructured":"Waring ME, McManus RH, Saczynski JS, Anatchkova MD, McManus DD, Devereaux RS et al. Transitions, risks, and actions in coronary events\u2014center for outcomes research and education (TRACE-CORE): design and rationale. Circ: Cardiovascular Quality and Outcomes. 2012;5(5).","DOI":"10.1161\/CIRCOUTCOMES.112.965418"},{"issue":"6","key":"3017_CR22","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1097\/00005650-199206000-00002","volume":"30","author":"JE Ware Jr","year":"1992","unstructured":"Ware JE Jr., Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care. 1992;30(6):473\u201383.","journal-title":"Med Care"},{"issue":"9","key":"3017_CR23","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1046\/j.1525-1497.2001.016009606.x","volume":"16","author":"K Kroenke","year":"2001","unstructured":"Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001;16(9):606\u201313.","journal-title":"J Gen Intern Med"},{"issue":"11","key":"3017_CR24","doi-asserted-by":"publisher","first-page":"2218","DOI":"10.1016\/j.jacc.2006.07.063","volume":"48","author":"N Rieckmann","year":"2006","unstructured":"Rieckmann N, Gerin W, Kronish IM, Burg MM, Chaplin WF, Kong G, et al. Course of Depressive Symptoms and Medication Adherence After Acute Coronary Syndromes. J Am Coll Cardiol. 2006;48(11):2218\u201322.","journal-title":"J Am Coll Cardiol"},{"key":"3017_CR25","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.jpsychores.2017.02.015","volume":"97","author":"CT Liss\u00e5ker","year":"2017","unstructured":"Liss\u00e5ker CT, Wallert J, Held C, Olsson E. Emotional distress as a predictor of statin non-adherence among Swedish first-time myocardial infarction patients, 2006\u20132013. J Psychosom Res. 2017;97:30\u20137.","journal-title":"J Psychosom Res"},{"issue":"9","key":"3017_CR26","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.1016\/j.amjcard.2011.12.017","volume":"109","author":"LK Bauer","year":"2012","unstructured":"Bauer LK, Caro MA, Beach SR, Mastromauro CA, Lenihan E, Januzzi JL, et al. Effects of Depression and Anxiety Improvement on Adherence to Medication and Health Behaviors in Recently Hospitalized Cardiac Patients. Am J Cardiol. 2012;109(9):1266\u201371.","journal-title":"Am J Cardiol"},{"issue":"7","key":"3017_CR27","first-page":"e87344","volume":"17","author":"S Nafees","year":"2025","unstructured":"Nafees S, Ali N, Wandala A, Hussain Z, AlShaharli AG, Mussadiq K, et al. Association Between Depression and Medication Adherence Among Post-myocardial Infarction Patients in a South Asian Clinical Setting. Cureus. 2025;17(7):e87344.","journal-title":"Cureus"},{"key":"3017_CR28","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.socscimed.2015.05.041","volume":"138","author":"J Berntson","year":"2015","unstructured":"Berntson J, Stewart KR, Vrany E, Khambaty T, Stewart JC. Depressive symptoms and self-reported adherence to medical recommendations to prevent cardiovascular disease: NHANES 2005\u20132010. Soc Sci Med. 2015;138:74\u201381.","journal-title":"Soc Sci Med"},{"issue":"19","key":"3017_CR29","doi-asserted-by":"publisher","first-page":"1839","DOI":"10.1212\/WNL.0000000000003910","volume":"88","author":"KC Albright","year":"2017","unstructured":"Albright KC, Zhao H, Blackburn J, Limdi NA, Beasley TM, Howard G, et al. Racial differences in statin adherence following hospital discharge for ischemic stroke. Neurology. 2017;88(19):1839\u201348.","journal-title":"Neurology"},{"key":"3017_CR30","doi-asserted-by":"publisher","first-page":"637398","DOI":"10.3389\/fgwh.2021.637398","volume":"2","author":"SH Bots","year":"2021","unstructured":"Bots SH, Inia JA, Peters SAE. Medication Adherence After Acute Coronary Syndrome in Women Compared With Men: A Systematic Review and Meta-Analysis. Front Glob Womens Health. 2021;2:637398.","journal-title":"Front Glob Womens Health"},{"issue":"2","key":"3017_CR31","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1177\/2047487317744363","volume":"25","author":"DC Eindhoven","year":"2018","unstructured":"Eindhoven DC, Hilt AD, Zwaan TC, Schalij MJ, Borleffs CJW. Age and gender differences in medical adherence after myocardial infarction: Women do not receive optimal treatment \u2013 The Netherlands claims database. Eur J Prev Cardiolog. 2018;25(2):181\u20139.","journal-title":"Eur J Prev Cardiolog"},{"issue":"4","key":"3017_CR32","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1016\/j.jacl.2016.02.016","volume":"10","author":"DG Karalis","year":"2016","unstructured":"Karalis DG, Wild RA, Maki KC, Gaskins R, Jacobson TA, Sponseller CA, et al. Gender differences in side effects and attitudes regarding statin use in the Understanding Statin Use in America and Gaps in Patient Education (USAGE) study. J Clin Lipidol. 2016;10(4):833\u201341.","journal-title":"J Clin Lipidol"},{"issue":"23","key":"3017_CR33","doi-asserted-by":"publisher","first-page":"e022883","DOI":"10.1161\/JAHA.121.022883","volume":"10","author":"AM Kerola","year":"2021","unstructured":"Kerola AM, Palom\u00e4ki A, Rautava P, Nuotio M, Kyt\u00f6 V. Sex Differences in Cardiovascular Outcomes of Older Adults After Myocardial Infarction. JAHA. 2021;10(23):e022883.","journal-title":"JAHA"},{"issue":"7","key":"3017_CR34","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1161\/CIRCULATIONAHA.113.002658","volume":"129","author":"JC Lauffenburger","year":"2014","unstructured":"Lauffenburger JC, Robinson JG, Oramasionwu C, Fang G. Racial\/Ethnic and Gender Gaps in the Use of and Adherence to Evidence-Based Preventive Therapies Among Elderly Medicare Part D Beneficiaries After Acute Myocardial Infarction. Circulation. 2014;129(7):754\u201363.","journal-title":"Circulation"},{"issue":"16","key":"3017_CR35","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1016\/j.jacc.2018.02.032","volume":"71","author":"SAE Peters","year":"2018","unstructured":"Peters SAE, Colantonio LD, Zhao H, Bittner V, Dai Y, Farkouh ME, et al. Sex Differences in High-Intensity Statin Use Following Myocardial Infarction in the United States. J Am Coll Cardiol. 2018;71(16):1729\u201337.","journal-title":"J Am Coll Cardiol"},{"key":"3017_CR36","doi-asserted-by":"publisher","first-page":"29","DOI":"10.2147\/PPA.S502645","volume":"19","author":"J Rosenberg","year":"2025","unstructured":"Rosenberg J, Lampridou S, Moores A, Garfield S, Wingfield D, Judah G. A Systematic Review Uncovering Modifiable Influences on Statin Adherence. PPA. 2025;19:29\u201348.","journal-title":"PPA"},{"issue":"6","key":"3017_CR37","first-page":"586","volume":"8","author":"K Smolina","year":"2015","unstructured":"Smolina K, Ball L, Humphries KH, Khan N, Morgan SG. Sex Disparities in Post-Acute Myocardial Infarction Pharmacologic Treatment Initiation and Adherence: Problem for Young Women. Circ: Cardiovasc Qual Outcomes. 2015;8(6):586\u201392.","journal-title":"Circ: Cardiovasc Qual Outcomes"},{"issue":"10","key":"3017_CR38","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.3390\/metabo13101087","volume":"13","author":"V Venditti","year":"2023","unstructured":"Venditti V, Bleve E, Morano S, Filardi T. Gender-Related Factors in Medication Adherence for Metabolic and Cardiovascular Health. Metabolites. 2023;13(10):1087.","journal-title":"Metabolites"},{"issue":"2","key":"3017_CR39","doi-asserted-by":"publisher","first-page":"163","DOI":"10.5551\/jat.64848","volume":"32","author":"Y Takahashi","year":"2025","unstructured":"Takahashi Y, Morimoto T, Iekushi K, Arai H. A Medical Claims Database Study of Factors Associated with Medication Adherence and Treatment Persistence in Patients Receiving PCSK9 Monoclonal Antibodies. J Atheroscler Thromb. 2025;32(2):163\u201375.","journal-title":"J Atheroscler Thromb"}],"container-title":["Lipids in Health and Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12944-026-03017-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12944-026-03017-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12944-026-03017-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T07:24:13Z","timestamp":1792135453000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12944-026-03017-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,22]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3017"],"URL":"https:\/\/doi.org\/10.1186\/s12944-026-03017-x","relation":{},"ISSN":["1476-511X"],"issn-type":[{"value":"1476-511X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,22]]},"assertion":[{"value":"18 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Institutional Review Board (IRB) approval was obtained for the parent TRACECORE study from the Committee for the Protection of Human Subjects in Research at the University of Massachusetts Medical School (UMMS) and the other study sites. The other sites include Saint Vincent Hospital\/Fallon Clinic\/Fallon Community Health Plan Research Review Committee IRB, Medical Center of Central Georgia IRB, Mercer University IRB and Office of Research Compliance, Kaiser Permanente Georgia IRB, Northside Hospital IRB.\u00a0","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"211"}}